We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
(-35%)
Cap. Flow
-$2.45B
Cap. Flow
% of AUM
-63.69%
Top 10 Holdings %
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$175M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$26.7M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$12.1M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$11.3M |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$9.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$120M |
| 2 |
Microsoft
MSFT
|
+$115M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$72.4M |
| 4 |
Amazon
AMZN
|
+$69.8M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.05% |
| 2 | Consumer Discretionary | 11.67% |
| 3 | Healthcare | 9.59% |
| 4 | Financials | 9.24% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Scorpio Tankers
STNG
$3.81B
| $182K | ﹤0.01% |
8,224
-4,490
| -35% | -$91.2K |
|
2002
Anavex Life Sciences
AVXL
$310M
| $181K | ﹤0.01% |
7,907
-12,278
| -61% | -$182K |
|
2003
WisdomTree US Multifactor Fund
USMF
$303M
| $181K | ﹤0.01% |
4,607
-3,435
| -43% | -$134K |
|
2004
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.3B
| $180K | ﹤0.01% |
+3,858
| New | +$171K |
|
2005
Minerals Technologies
MTX
$2.34B
| $180K | ﹤0.01% |
2,289
-12,507
| -85% | -$1.01M |
|
2006
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$79.4M
| $179K | ﹤0.01% |
+2,917
| New | +$183K |
|
|
SWN
2007
DELISTED
Southwestern Energy Company
SWN
| $179K | ﹤0.01% |
31,503
-52,049
| -62% | -$256K |
|
|
ARNA
2008
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $179K | ﹤0.01% |
2,627
-3,841
| -59% | -$250K |
|
2009
CytomX Therapeutics
CTMX
$754M
| $178K | ﹤0.01% |
28,103
+16,742
| +147% | +$130K |
|
2010
Sonic Automotive
SAH
$2.61B
| $178K | ﹤0.01% |
3,969
-10,626
| -73% | -$516K |
|
|
AJRD
2011
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $178K | ﹤0.01% |
3,687
-14,391
| -80% | -$691K |
|
|
TWNK
2012
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $177K | ﹤0.01% |
10,908
-4,555
| -29% | -$71K |
|
|
SJR
2013
DELISTED
Shaw Communications Inc.
SJR
| $177K | ﹤0.01% |
6,127
-1,954
| -24% | -$56.4K |
|
2014
AtriCure
ATRC
$2.11B
| $176K | ﹤0.01% |
2,214
-1,185
| -35% | -$86.1K |
|
2015
Abits Group
ABTS
$4.09M
| $175K | ﹤0.01% |
+524
| New | +$83.1K |
|
2016
Agios Pharmaceuticals
AGIO
$1.93B
| $175K | ﹤0.01% |
3,181
+1,670
| +111% | +$93.4K |
|
2017
Alector
ALEC
$199M
| $175K | ﹤0.01% |
8,398
+6,259
| +293% | +$118K |
|
2018
Motorcar Parts of America
MPAA
$258M
| $175K | ﹤0.01% |
7,823
+6,421
| +458% | +$146K |
|
2019
Phibro Animal Health
PAHC
$1.39B
| $175K | ﹤0.01% |
6,060
+2,163
| +56% | +$58.5K |
|
2020
Unifirst Corp
UNF
$5.25B
| $175K | ﹤0.01% |
745
-2,861
| -79% | -$642K |
|
2021
Butterfly Network
BFLY
$2.35B
| $174K | ﹤0.01% |
12,015
-2,096
| -15% | -$28.3K |
|
|
MAG
2022
DELISTED
MAG Silver
MAG
| $174K | ﹤0.01% |
8,295
+5,750
| +226% | +$114K |
|
2023
MicroSectors U.S. Big Oil 3x Leveraged ETNs due Feb 17 2045
NRGU
$19.2M
| $174K | ﹤0.01% |
+1,001
| New | +$155K |
|
|
TARO
2024
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $174K | ﹤0.01% |
2,424
+685
| +39% | +$50.3K |
|
|
BFX
2025
DELISTED
BowFlex Inc.
BFX
| $174K | ﹤0.01% |
10,329
-6,051
| -37% | -$102K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review
As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.
- Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
- Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
- Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
- Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
- Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
- Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.